Efficacy and Safety of Efgartigimod in the Treatment of Amyotrophic Lateral Sclerosis (ALS): A Retrospective Cohort Study (P11-11.031)

To evaluate the efficacy and safety of efgartigimod in the treatment of ALS in China.

Authors

Institutions

Publication Details

Journal
Neurology
Published
2025-04-07
DOI
https://doi.org/10.1212/wnl.0000000000211063
Primary Topic
Amyotrophic Lateral Sclerosis Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy and Safety of Efgartigimod in the Treatment of Amyotrophic Lateral Sclerosis (ALS): A Retrospective Cohort Study (P11-11.031)

Youna Xie, Xinyu Yang, Ming-Ying Zheng, Xiaoli Yao et al.
Neurology
Amyotrophic Lateral Sclerosis Research
article

Efficacy and Safety of Efgartigimod in the Treatment of Amyotrophic Lateral Sclerosis (ALS): A Retrospective Cohort Study (P11-11.031)

Youna Xie, Xinyu Yang, Ming-Ying Zheng, Xiaoli Yao, Yuxin Wang, Sen Huang, Zhanhua Zhong
article en

Abstract

To evaluate the efficacy and safety of efgartigimod in the treatment of ALS in China.

NeurologyVol. 104(7_Supplement_1)
Sun Yat-sen University (CN)
Good health and well-being
Openalex Percentile: Top 88%
Amyotrophic Lateral Sclerosis Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.